Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

Also called NCT02545231

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02545231
Other papers using this trial's data
  • Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis Heart and vessels, 2019-01 DOI, PubMed 30047013

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02545231. Randomized; double masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2018-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
Acronym
ELEVATE
Condition
Atherosclerosis
Condition
Neointima
Condition
Angina
Intervention (Drug)
Pitavastatin 1mg
Intervention (Drug)
Pitavastatin 4mg
Intervention (Drug)
Placebo
Lead sponsor
Korea University Anam Hospital (class: other)

Record details

Record id
cardio:ct-nct02545231
Content hash
81e462ec9f270e58e89a5df6625a82a1f3ab60a80ddb4a683f7cb42c64bf6dc1